Literature DB >> 3550143

Monoclonal antibodies: state of the art.

N H Bander.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3550143     DOI： 10.1016/s0022-5347(17)44154-1

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  7 in total

1.  Clinical studies on bladder tumor-associated antigen in serum of patients with bladder cancer by using monoclonal antibody and sandwich ELISA.

Authors:  S S Zhu; Y C Zhang; R Z Hu; Z Q Ye; C J Li; Q A Lin
Journal:  J Tongji Med Univ       Date:  1990

2.  Regulation of glucocorticoid receptors and Na-K ATPase activity by hydrocortisone in proximal tubular epithelial cells.

Authors:  D Ellis; T D Sothi; N P Curthoys; B Ballou; E D Avner
Journal:  In Vitro Cell Dev Biol       Date:  1988-08

Review 3.  New treatment approaches for metastatic renal cell carcinoma.

Authors:  D M Nanus
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

4.  Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A.

Authors:  D M Nanus; D Engelstein; G A Gastl; L Gluck; M J Vidal; M Morrison; C L Finstad; N H Bander; A P Albino
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

5.  Autologous antibodies to human bladder cancer.

Authors:  H B Grossman; G Wedemeyer; J Stein
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progression.

Authors:  D M Nanus; S A Ebrahim; N H Bander; F X Real; L M Pfeffer; J R Shapiro; A P Albino
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

Review 7.  Advanced renal cell carcinoma.

Authors:  M I Milowsky; D M Nanus
Journal:  Curr Treat Options Oncol       Date:  2001-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.